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{1}  Good afternoon.  I’m very pleased to be here.  I appreciate the offer and the invitation from the 
Richmond Journal of Law & Technology to speak at this conference.  This final panel is really about 
liability issues related to genetically modified foods or transgenic crops.  Now I just want to quickly 
introduce these three people, and I’m going to start on my far side with Rachel Lattimore.  Rachel 
Lattimore is a lawyer with the firm of Arent Fox in Washington D.C., and she is going to focus her 
talk – and we’ve sort of agreed among ourselves so we don’t step on each other’s toes – she’s going 
to focus her talk really in one sense on corn and the issues about the coexistence between transgenic 
crops and organic crops.  Don Uchtmann, who is next to me, is a professor in the College  of 
Agriculture at the University of Illinois, and he has done a lot of work in the area of StarLink.  He is 
really going to talk about the impact of StarLink and the legal liability that has arisen out of StarLink.  
I’m Drew Kershen from the University of Oklahoma College of Law, and I’m going to talk about the 
liability for not using genetically modified organisms.
{2}  Okay, let me get to the risk of growing non-GMO and just talk about that.  I’m only going to talk 
about three risks in about the next ten to twelve minutes.  The risk of product liability for foods, the 
risk of environmental compliance relating to pesticides, and the risk I call “broader social risk” or the 
risk of scientific ignorance which relates to future developments.
{3}  Let me talk about the risk of product liability.  There have been a number of companies that have 
responded to activist campaigns by announcing that they were not going to use transgenic crops for 
ingredients in their foods.  There have been a number of prominent names among food companies that 
readily come to mind.  I would just say that they’re taking tremendous risk by doing this – tremendous 
risk of legal liability – by making this decision.  Not just in a societal sense, about which I will also 
talk, but take immediate risk right now.  The food companies are acting as if they are unaware that the 
Restatement of Torts for Products Liability, that specifically for the first time in the Restatement of 
Torts, makes it clear that food is now subject, fully and completely, to product liability.
{4}  Food is now like any other product and subject to products liability.  That means it’s subject to a 
manufacturing defect.  Manufacturing defect would be such things as if you had glass in a Coca Cola, 
or if you had a toxic poison in baby food, or whatever it is.  By the way, that’s not an unusual tort.  It’s 
a tort that has been around for a long time.  It’s a tort that has existed for a long time, and that’s really 
not unusual because, obviously, your food is not meant to have that kind of manufacturing defect in it.  
{5}  Having a genetically modified organism as an ingredient is not at risk of being a manufacturing 
defect, as long as it has passed the regulatory provisions.  It’s not going to be a manufacturing defect.  
What is really a risk, and this is what is now made clear in the Restatement, is that food companies 
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had this manufacturing design before, but now with food being fully and completely accountable to 
the products liability there are two other kinds of products liability: design liability and also inadequate 
warning or instructions liability.  I’m going to focus on the design liability.  
{6}  Design liability means that companies now have an obligation to use a design for their product 
which, if there is a reasonable alternative design that lessens the risk of something, then they have the 
obligation to use that reasonable alternative design.  And this section also makes it explicitly clear that 
consumer expectations about the product is not a defense against design liability.  That is, consumer 
expectations or consumer demands or consumer fears that might have been generated by activist groups 
are not a defense.  You are required, under products liability, to use reasonable alternative designs.  And 
if you say, “But I want to appeal to product niches or to specific consumer demands,” then the answer 
becomes, “Well, you can do that if you want to if you think you still have an alternative which is still 
a reasonable alternative.  But if it’s not the best alternative, then you can still do it, as long as you put 
on adequate warnings and instructions on the label.”  If food companies do not add adequate warnings, 
they are then subjected to this third product liability – that is, the inadequate warning and instruction.
{7}  Now let me just tell you how this is going to work out and begin to play out with respect to 
agricultural biotechnology.  Let me just talk about peanuts.  Peanuts are a significant risk to a number 
of people and a significant percent of the population.  I don’t mean large numbers, I just mean it’s 
a significant allergy.  And those risks are significant.  That is, a peanut allergy, for example, can, in 
fact, kill you.  Not all allergies will kill you, but peanuts very definitely can.  There are a number of 
companies that have well into development now – past the laboratory stage and well into the research 
test phases – the development of hypoallergenic peanuts, which have been developed with a method 
using agricultural biotechnology.  There are various methods, and I don’t need to go into the methods 
to do that, but there are various methods by which this can be done.  And so there will be, very shortly, 
companies applying for permission to commercialize – and by this I mean in the next two to three years, 
or maybe four – to commercialize peanuts that no longer contain the allergen.
{8}  Now, again, biotechnology is not the only technique or technology that could maybe create 
hypoallergenic peanuts.  In fact, you may have been reading in the papers these last few days about a 
company – I believe it’s out of New Orleans but it’s irrelevant – that has a vaccine that they’re talking 
about.  And that vaccine will protect you from the allergies of peanuts.  So biotechnology is not the only 
way, and that point is going to come back in a few minutes.  But what I was going to ask you is once 
these are commercialized, once peanut farmers could grow hypoallergenic peanuts, what would be the 
defense for a food company for not using that reasonable alternative?  What would be the defense?
{9}  “My regret is that your child only had one life to give for a natural peanut?”  It’s not going to float.  
And it’s not a defense in consumer expectations.  Now a few are going to say, “Oh, wait a second.  If 
you have a reasonable alternative, you can then give label warnings.”  Well, yes, you can give label 
warnings.  You could say “I am using peanuts that still contain the allergy and I’m doing this.”  And you 
better put adequate warnings, and I don’t know what they would all be, but you better be careful about 
that.  
{10}  But remember, a lot of  the times that you see young children come into contact with peanuts 
it isn’t through labeling because first of all young children often don’t have the ability to read.  They 
haven’t gone to school yet.  They were over at a neighbor’s.  That’s what happened to a child in 
Oklahoma just about two months ago.  The child was at a neighbor’s.  And the neighbor child said, 
“Let’s have a cookie.”  That sounded like a good idea.  It is a good idea.  Except the cookie, of course, 
because the child doesn’t know, is a peanut cookie.  And then you’ve got trouble.  Any company that 
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would use that kind of peanut is at great risk of being held in products liability for design defect, when 
there is a reasonable alternative that’s been completely approved by the FDA, completely approved by 
the USDA, and completely approved by the EPA.  Any company that doesn’t do that is at risk.  I don’t 
want a single child to die, but I will tell you, if one does, I want the case, because I’m going to own the 
food company.  I’m going to hold them liable.  Because there is no excuse.  None.  It’s not going to be 
an excuse, and the food company will have to face the risk of product liability for refusing to deal with 
reasonable alternatives.
{11}  Peanuts are the farthest along, but shellfish, shrimp and prawns have significant allergies, too.  
A researcher at Tulane and several others are well along in the laboratory research of removing these 
allergens.  And the research is just beginning with respect to soybeans and wheat.  What I’m saying to 
you is that food companies that let activists scare them into stopping and announcing that they won’t use 
agriculture biotechnology have already turned into a dead end.  A dead end that’s going to be very costly 
in terms of products liability.  
{12}  What about environmental risk?  EPA is presently reevaluating  lots of pesticides, such as 
organophosphates, which I’ll just use as one example. Organophosphates have been approved.  They 
are very effective, but they do have some real risk to them about which we have evidence, such as 
environmental harms.  They’re also toxic instantly in terms of exposure to workers and so you have 
workers who at times get sick from the use of organophosphates.  And so you have both environmental 
harms and worker harm.  There’s a real possibility that there will be registration revocation of some 
of these organophospates.  But even if there isn’t revocation, the EPA has the authority to begin to put 
conditions on the use of pesticides, such as best management practices for what you can do, or best 
management practices for how you can farm in light of environmental harms or worker safety, though 
some of that may lap over into OSHA.
{13}  Moreover, the EPA has authority for what’s called technology-forcing standards.  Now, I don’t 
mean that EPA is going to force a particular technology.  I’m just saying that EPA has the authority to 
nudge you – and sometimes more than nudge you – and push towards standards that force the adoption 
of different technologies. 
{14}  How does this relate to agricultural biotechnology?  I’m going to use potato farming as an 
example.  Monsanto and several other companies created a whole set of transgenic potatoes that were 
basically immunized from a variety of potato diseases, such as the Colorado beetle, such as viruses 
and blights.  Farmers grew these transgenic potato varieties.  Farmers began to use them like mad in 
the Pacific Northwest – your Idaho potato people and Washington.  What the farmers liked most of all 
was they had reduced all these pesticides.  As a practical matter, organophosphate usage was reduced 
significantly.  That protected the family of the farmers.  It protected the workers.  And it also protected 
the environment from fish kills and runoffs that occurred.  It was a technology that had all sorts of 
advantages to it, until food companies responded to activists’ food scares and began to announce the 
companies would not use French fries that had transgenic ingredients.  Food chains like McDonald’s, 
Wendy’s, McCain’s in Canada, began to say they wouldn’t use  transgenic potatoes.  And when the 
companies began to say they wouldn’t use transgenic potatoes, processors stopped buying transgenic 
potatoes.  And in response to the kinds of things that other panelists earlier talked about, when the food 
processors then sent those messages back, the message got included in contract clauses prohibiting 
the use of agricultural biotechnology.  And when you put those clauses in prohibiting agricultural 
biotechnology, it meant that the technology basically disappeared.  It’s still out there, it’s still patented, 
but it has disappeared.  With all these advantages, it has disappeared.
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{15}  What’s the impact of that on Prince Edward Island, which is a major Canadian province growing 
potatoes for french fries.  It means last summer they had six major fish kills.  They have a huge debate 
going on about that.  And, one of the leaders of the potato industry in the discussions said recently, 
“Well, you know what?  We really have a way of solving all of this if you just let us use biotechnology.” 
And then he said, the fear that activist groups have generated has prevented  PEI potato farmers from 
using agricultural biotechnology and has blocked us from using the best technology.  What I’m saying 
to you is, if food companies pushed contract clauses in their agreements with farmers which prohibit 
them from using a better technology, the food companies have caused the injuries, and they may be 
liable for the injuries.  In my opinion, that requires some expansion of liability for food companies but 
I’m willing to argue and I’m willing to bet that I would have a good chance of winning.  Right now 
we are killing fish and harming workers for no good reason other than fearmongering.  Fearmongering 
– putting people in fear of agricultural biotechnology.  That liability theory, it would be my hope 
someday, would go back to include the activist organizations for creating this.  I’m working on these 
theories in my mind.  Liability theories should be for those who caused the harms.  Those who have 
no respect for other peoples’ lives and who claim to be protecting the environment and then let fish die 
when there is no good reason.
{16}  What’s the risk for scientific developments?  Agricultural biotechnology, as I’ve just said, is 
having problems because of what I consider to be fearmongering.  There are several things about the 
risk of scientific ignorance taking hold on our society.  One is product development as a general name.  
This isn’t just about market share.  It is true that companies will certainly try to use technologies to 
develop market share.  But it’s about blocking the development of nutritional products.  It’s about 
blocking the development of biotechnology products in pharmaceuticals or industrials because we 
will have these debates and fearmongering about food.  And so it’s not about market share.  It’s about 
product development.  It’s about product development in a broader sense about products that I think we 
need to have.
{17}  But it’s interesting to me that the science is not going to stop.  The science is going to go on.  
And plaintiffs’ lawyers, when these harms occur, are not going to say, “Oh, we’re going to ignore this 
science on the theory of, well, we didn’t let the products develop.”  No, plaintiffs’ lawyers are going 
to come back the same way they have in all the other things about whether you could put covers over 
drive chains or whether you could put roll bars on tractors.  They’re going to say there was a technology 
available, and be willing to argue to the jury, “The company had an alternative and therefore the 
company caused these harms.”  In other words, the loss of product development isn’t just a loss of these 
new products.  It’s putting the companies back at risk again of facing plaintiffs’ attorneys saying that 
companies not only stopped product development but, because of marketing concerns, caused personal 
injuries and environmental harms.  Plaintiffs’ attorneys will point to the science.  And I’m enough of a 
Plaintiffs’ attorney again to know that Plaintiffs’ attorneys don’t give a hoot which side the science turns 
out to be on, as long as it’s the winning side for plaintiffs.  So plaintiffs’ lawyers will use the science 
tomorrow to win a good verdict.
{18}  But I want to talk about a broader policy, and that’s about poverty alleviation.  The impact of 
these debates has really been significantly harmful in terms of poverty alleviation around the world, 
in terms of impact on developing nations.  Developing nations have been put in fear of using these 
products.  They’ve been put in fear of eating the food from these products as we’ve seen in the Zambian 
situation and the famine in Zambia.  But the impact on these developing nations has been really a 
detrimental impact in terms of their ability to really begin to be nations that are hoping to escape their 
poverty.  And I just want to give two quick examples.
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{19}  The transgenic potato.  I have already talked about transgenic potato varieties in America.  But 
in the next slide that I’ll just show in a minute, there’s a researcher at the University of Leeds in the 
U.K., who has developed transgenic potatoes specifically with a poverty focus for Bolivia, because in 
Bolivia potato is the major food.  Most of the farms are very small.  The entire farm is used for growing 
potatoes.  Potatoes are a wonderful food in terms of starch.  They’re not very good for all the other 
things that give you health, called micronutrients.  And what he says is that he thinks he can increase 
production by 50 or 60 percent with a transgenic potato resistant to diseases.  That means Bolivian 
farmers could reduce their land use for the production of potatoes by half and feed their family with 
potatoes.  What could the Bolivian farmers do with the land no longer devoted to producing potatoes?  
Maybe to grow other kinds of foods like beans, or squash, or other things that give you the kind of 
health that would be good.
{20}  Now, what’s the other example and then I’ll just end?  The transgenic protato.  I read today on 
the plane about a product out of an Indian Institute of Science.  And the Institute had a product called 
protato.  The protato is a potato with all the starch and all the energy that comes from the starch of 
potatoes.  Indian agricultural scientists have transferred a gene into it so it picks up all the protein-rich 
elements of the amaranth and particularly some essential amino acids that are required for good health.  
And here’s what the Indian scientist said at the end of the article.  He said, “I only hope that activists do 
not demonize my protato the same way they demonized golden rice.”  Golden rice is rice fortified with 
vitamin A by using agricultural biotechnology. Thank you very much.
____________________________________________________________________________________________________
* Drew Kershen is the Earl Sneed Centennial Professor of Law at the University of Oklahoma School of Law 
where he teaches courses on agricultural law, legal history, professional responsibility, and water rights.  Mr. 
Kershen has published over thirty law review articles throughout his career, and he is coauthor of Farm Products 
Financing and Filing Service, written in 1990 with J. Thomas Hardin.  He is a past member of the Board of 
Directors and past president of the American Agricultural Law Association, and he served as a trustee to the 
Rocky Mountain Mineral Law Foundation from 1991-1995.  He currently serves as a Co-Reporter for the UCC 
Article 7 Revision Committee.  Mr. Kershen received his B.A. from Notre Dame in 1966, his J.D. from the 
University of Texas in 1968, and his LL.M. from Harvard University in 1975.
